CD44 and breast carcinoma: Previous work showed that the application of FSS can enrich the CSC-like subpopulation (CD44+/CD24−) in MCF-7 breast cancer cells but not in MDA-MB-231 breast cancer cells that already have a high percentage of CSC-like subpopulation [45].